An Integrated Approach to Preventing Surgical Site Infections: Addressing the Four Sources of Healthcare-Associated Contamination
J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, IP-BC, PLNC, CFER, AS-BC, VA-BC, CMRP, HACP, HACP-IC, HACP-PE, LTC-CIP, CIC, AL-CIP, CAIP, DICO-C, CPPS, CCHR-S, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, CHIPP-B, FACDONA, FAAPM, eFACHDM, FAPIC, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA

Surgical Site Infections (SSIs) remain one of the most persistent and costly healthcare-associated infections (HAIs), accounting for nearly 20% of all HAIs and contributing to increased morbidity, prolonged hospital stays, and significant financial burden. Despite decades of progress, the complexity of the perioperative environment demands that healthcare leaders take an integrated, multidisciplinary approach to SSI prevention—one that simultaneously addresses the four most common sources of contamination and transmission within healthcare: (1) contaminated hands of healthcare workers and patients, (2) the contaminated clinical environment, (3) the patient’s own microbiome, and (4) contaminated air in healthcare facilities.
1. The Contaminated Hands of Healthcare Workers and Patients
The first and most fundamental source of microbial transmission remains the hands of those who provide and receive care. Numerous studies confirm that hand hygiene compliance rates in perioperative settings often fall below optimal targets, particularly during high-acuity or time-sensitive care. The World Health Organization’s (WHO) Five Moments for Hand Hygiene framework and the Centers for Disease Control and Prevention (CDC) guidelines both emphasize hand hygiene before aseptic tasks, after glove removal, and before patient contact.
In the surgical environment, the risk extends beyond direct contact. Staff frequently handle sterile instruments, devices, and drapes, where even minor lapses in technique can lead to contamination. Implementing hand hygiene monitoring technologies, competency validation programs, and environmental nudges—such as visual cues and workflow-integrated sanitizing stations—can substantially increase compliance. Patient education is equally critical. Preoperative reminders to perform hand hygiene before wound care or dressing changes can reduce microbial transfer postoperatively, when infection risk remains high.
Value analysis professionals play an important role by evaluating not just the cost but the usability, compliance support, and workflow integration of hand hygiene systems. Products that simplify compliance—such as sensor-based dispensers or performance dashboards—add measurable value to infection prevention initiatives.
2. The Contaminated Clinical Environment of Care
The second source of SSI transmission lies in the clinical environment itself—the surfaces, equipment, and medical devices that surround the patient. Inadequate cleaning, biofilm formation, and residual contamination on high-touch or difficult-to-clean surfaces can perpetuate cross-contamination cycles.
Environmental hygiene must be considered a core infection prevention competency, not a secondary housekeeping task. The CDC’s Guidelines for Environmental Infection Control in Health-Care Facilities outline the importance of selecting EPA-registered disinfectants with proven efficacy against pathogens such as Staphylococcus aureus, C. difficile, and multidrug-resistant organisms. Perioperative leaders should ensure that disinfection protocols include real-time verification of cleaning effectiveness, using fluorescent markers or adenosine triphosphate (ATP) testing.
From a value analysis perspective, environmental disinfection technology must be assessed holistically—considering not only the per-unit cost but also turnover efficiency, staff training requirements, and reduction in environmental bioburden. Automated disinfection systems, such as ultraviolet (UV) or continuous air-surface disinfection units, can complement manual cleaning by reducing residual contamination between cases.
3. The Contaminated Microbiome of the Perioperative Patient
The third—and perhaps least visible—source of SSI transmission is the patient’s own microbiome. Every patient brings a complex ecosystem of microorganisms that, when disrupted, can become a source of infection. The perioperative period introduces numerous opportunities for microbial transmission: hair clipping, skin antisepsis, surgical draping, and incision management.
Evidence-based strategies are well-established but inconsistently applied. For example, the CDC and Association of periOperative Registered Nurses (AORN) recommend clipping (not shaving) hair at the surgical site immediately before surgery to reduce micro-abrasions that promote bacterial growth. Likewise, preoperative chlorhexidine bathing, nasal decolonization protocols, and optimized preoperative antibiotic timing all reduce endogenous contamination risk.
Value analysis teams must ensure that products used for preoperative preparation—skin antiseptics, drapes, prepping kits—are selected not only for cost efficiency but also for clinical efficacy, ease of use, and compliance with manufacturer instructions for use (IFUs).
Additionally, perioperative leaders should implement competency assessments to verify adherence to standardized preoperative skin preparation protocols. By integrating patient-centered education, antimicrobial stewardship, and consistent preoperative protocols, healthcare organizations can minimize the microbiological burden the patient brings into the operating room.
4. The Contaminated Air Within Healthcare
Airborne contamination is an often-underestimated factor in SSI prevention, despite strong evidence linking airborne particulate levels to surgical wound contamination. Traditional ventilation systems, even when compliant with ASHRAE Standard 170, are designed to dilute—not eliminate—airborne microbes. Surgical lights, foot traffic, and door openings disrupt laminar airflow and resuspend particles, increasing risk during procedures.
An integrated air quality strategy combines ventilation optimization, continuous air disinfection technologies, and environmental monitoring. Systems such as the Aerobiotix Illuvia® Sense demonstrate how continuous air decontamination using HEPA filtration and UV germicidal technology can significantly reduce airborne microbial load without interfering with existing HVAC systems.
Perioperative value analysis professionals should evaluate air quality technologies using measurable outcomes: reductions in particle counts, colony-forming units (CFUs), and SSI rates. Air monitoring sensors that provide real-time data can enhance accountability and align environmental management with clinical performance metrics
The return on investment (ROI) of continuous air disinfection extends beyond infection reduction; it supports regulatory compliance, staff confidence, and operational resilience, particularly in high-risk procedural environments such as orthopedics, neurosurgery, and trauma.
An Integrated Framework for SSI Prevention
Each of these four sources—hands, environment, microbiome, and air—represents an essential control point in the chain of infection. Yet, true progress occurs only when they are addressed collectively through interprofessional collaboration among infection preventionists, perioperative nurses, surgeons, supply chain professionals, and value analysis experts.
An integrated SSI prevention program should include:
- Multidisciplinary governance: Linking infection prevention, surgical services, and supply chain oversight.
- Evidence-based product evaluation: Using standardized frameworks that balance clinical efficacy, operational feasibility, and financial stewardship.
- Continuous monitoring: Leveraging environmental and clinical data to identify trends and drive improvement.
- Education and accountability: Reinforcing competencies in hand hygiene, aseptic technique, and environmental control.
Surgical Site Infection prevention is not the responsibility of a single person, product, or department—it is the outcome of a system working in harmony. By addressing the four sources of contamination through a unified, evidence-based strategy, healthcare organizations can move beyond reactive infection control to proactive environmental safety. Through collaboration, innovation, and disciplined value analysis, hospitals can create perioperative environments that are not only sterile—but sustainably safe, efficient, and ready for every patient, every time.

Aerobiotix’s Illuvia Sense is uniquely positioned to help healthcare facilities exceed guidelines and reduce risk. This FDA-registered Class II medical device delivers continuous air decontamination and real-time monitoring, ensuring optimal air quality.
About the Author
J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, IP-BC, PLNC, CFER, AS-BC, VA-BC, CMRP, HACP, HACP-IC, HACP-PE, LTC-CIP, CIC, AL-CIP, CAIP, DICO-C, CPPS, CCHR-S, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, CHIPP-B, FACDONA, FAAPM, eFACHDM, FAPIC, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA
Dr. Garrett is an Adjunct Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine. He is Board Certified in Infection Prevention and Control, Advanced Leadership in Infection Control, Patient Safety, Healthcare Risk Management, and Healthcare Management and Leadership. Dr. Garrett is a Liaison to the AORN Guidelines Advisory Board.








